Friday, February 5, 2021

Decipher Biosciences Acquired By Veracyte

San Diego-based Decipher Biosciences, a precision oncology company developing treatments for urologic cancers, has been acquired by South San Francisco-based Veracyte. Veracyte said it will pay $600M in total consideration to Decipher's shareholders, split between $250M in cash and $350M in stock. As part of the acquisition, Decipher Biosciences'

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.